These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15502911)

  • 41. [Chemo-radiotherapeutic treatment of non-seminoma germ cell tumors of the testis in the advanced stage].
    Krengli M; Pastore G; Invernizzi A; Maffei S
    Minerva Med; 1987 Feb; 78(4):209-13. PubMed ID: 3031548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the blood-brain barrier relevant in metastatic germ cell tumor?
    Azar JM; Schneider BP; Einhorn LH
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):163-6. PubMed ID: 17707269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metachronous contralateral germ cell tumor 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies.
    von Ostau C; Krege S; Hartmann M; Rübben H
    Scand J Urol Nephrol; 2001 Oct; 35(5):430-1. PubMed ID: 11771876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of radiotherapy in stage I testicular seminomas: about 25 cases].
    Aissa A; Marnouche E; Elkacemi H; Kebdani T; Benjaafar N
    Pan Afr Med J; 2016; 25():53. PubMed ID: 28250877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
    Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
    Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
    Cohn-Cedermark G; Stahl O; Tandstad T;
    Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
    Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
    Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group.
    Fosså SD; Horwich A; Russell JM; Roberts JT; Cullen MH; Hodson NJ; Jones WG; Yosef H; Duchesne GM; Owen JR; Grosch EJ; Chetiyawardana AD; Reed NS; Widmer B; Stenning SP
    J Clin Oncol; 1999 Apr; 17(4):1146. PubMed ID: 10561173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study.
    Lee H; Kim JW; Hong SJ; Yang SC; Choi YD; Rha KH; Cho J
    Yonsei Med J; 2015 Jan; 56(1):24-30. PubMed ID: 25510743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
    Hallemeier CL; Pisansky TM; Davis BJ; Choo R
    Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radiotherapy for the treatment of testicular seminomas].
    Sancho Pardo G; Gómez de Segura G
    Arch Esp Urol; 2000; 53(6):505-16. PubMed ID: 11002519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent rhabdomyosarcoma after adjuvant chemotherapy for stage I non-seminomatous germ cell tumor with malignant transformation.
    Ushida H; Koizumi S; Katoh K; Okabe H; Okada Y; Okamoto K
    Int J Urol; 2013 May; 20(5):544-6. PubMed ID: 23072289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for clinical stage I nonseminomatous germ cell tumours.
    Vaughn DJ
    BJU Int; 2009 Nov; 104(9 Pt B):1381-6. PubMed ID: 19840017
    [No Abstract]   [Full Text] [Related]  

  • 55. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management options for stage I seminoma.
    Aparicio J; Díaz R
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1077-85. PubMed ID: 20645697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain metastases from testicular germ cell tumors: a retrospective analysis.
    Nonomura N; Nagahara A; Oka D; Mukai M; Nakai Y; Nakayama M; Nishimura K; Kakimoto K; Nakamura T; Usami M; Okuyama A; Miki T
    Int J Urol; 2009 Nov; 16(11):887-93. PubMed ID: 19863625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Management of clinical stage I testicular germ cell tumours].
    Loriot Y; Fizazi K
    Bull Cancer; 2007 May; 94(5):439-48. PubMed ID: 17535781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adjuvant treatment for stage I of testicular germ cell tumours].
    Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
    Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.